| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 7.46e-06 | 7 | 121 | 3 | GO:0004691 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 1.78e-05 | 9 | 121 | 3 | GO:0004690 | |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 2.52e-05 | 10 | 121 | 3 | GO:0004679 | |
| GeneOntologyMolecularFunction | acetyl-CoA carboxylase activity | 3.64e-05 | 2 | 121 | 2 | GO:0003989 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 7.52e-05 | 14 | 121 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 8.67e-05 | 74 | 121 | 5 | GO:0005548 | |
| GeneOntologyMolecularFunction | N-acylphosphatidylethanolamine-specific phospholipase D activity | 1.09e-04 | 3 | 121 | 2 | GO:0070290 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.33e-04 | 316 | 121 | 9 | GO:0035091 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.36e-04 | 129 | 121 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 2.20e-04 | 49 | 121 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | lipid binding | GPR31 CYTH3 CYTH2 INSR MYO1B GAB2 PITPNM1 TIAM1 PIK3C2B KCNJ1 DAPP1 PITPNM3 PLD1 PLD2 CADPS2 PSD4 | 3.10e-04 | 988 | 121 | 16 | GO:0008289 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.18e-04 | 151 | 121 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1C CACNB3 TRPC7 TRPC3 KCNJ1 LRRC8A ANO7 CNGA2 CNGA3 ANO3 | 4.87e-04 | 459 | 121 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | phospholipid binding | CYTH3 MYO1B GAB2 PITPNM1 TIAM1 PIK3C2B KCNJ1 DAPP1 PLD1 PLD2 PSD4 | 5.05e-04 | 548 | 121 | 11 | GO:0005543 |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 5.38e-04 | 6 | 121 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | biotin binding | 5.38e-04 | 6 | 121 | 2 | GO:0009374 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 7.50e-04 | 7 | 121 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | intracellularly cGMP-activated cation channel activity | 7.50e-04 | 7 | 121 | 2 | GO:0005223 | |
| GeneOntologyMolecularFunction | gated channel activity | 9.86e-04 | 334 | 121 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | phospholipase D activity | 9.96e-04 | 8 | 121 | 2 | GO:0004630 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1C CACNB3 TRPC7 TRPC3 SLC32A1 SLC15A1 KCNJ1 LRRC8A ANO7 ATP12A CNGA2 CNGA3 ANO3 | 1.05e-03 | 793 | 121 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.16e-03 | 193 | 121 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.28e-03 | 197 | 121 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1C CACNB3 TRPC7 TRPC3 KCNJ1 LRRC8A ANO7 CNGA2 CNGA3 ANO3 | 1.35e-03 | 525 | 121 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1C CACNB3 TRPC7 TRPC3 KCNJ1 LRRC8A ANO7 CNGA2 CNGA3 ANO3 | 1.37e-03 | 526 | 121 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 1.59e-03 | 10 | 121 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | phosphatidylinositol transfer activity | 1.93e-03 | 11 | 121 | 2 | GO:0008526 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1C CACNB3 TRPC7 TRPC3 PITPNM1 SLC32A1 SLC15A1 KCNJ1 PITPNM3 LRP2 LRRC8A ANO7 ATP11A ATP12A CNGA2 CNGA3 ANO3 | 1.97e-03 | 1289 | 121 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1C CACNB3 TRPC7 TRPC3 SLC32A1 SLC15A1 KCNJ1 ANO7 ATP12A CNGA2 CNGA3 ANO3 | 2.19e-03 | 758 | 121 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | receptor tyrosine kinase binding | 2.19e-03 | 90 | 121 | 4 | GO:0030971 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 2.31e-03 | 12 | 121 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 2.72e-03 | 13 | 121 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 2.72e-03 | 13 | 121 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 2.72e-03 | 13 | 121 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 2.72e-03 | 13 | 121 | 2 | GO:0016717 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.86e-03 | 231 | 121 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.16e-03 | 14 | 121 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | hormone binding | 3.58e-03 | 103 | 121 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 3.66e-03 | 51 | 121 | 3 | GO:0140303 | |
| GeneOntologyBiologicalProcess | malonyl-CoA biosynthetic process | 3.19e-05 | 2 | 117 | 2 | GO:2001295 | |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle assembly | 4.88e-05 | 13 | 117 | 3 | GO:0034380 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1C CACNB3 TRPC7 TRPC3 ADCYAP1R1 SLC32A1 SLC15A1 KCNJ1 DHRS7C PRKACA LRRC8A ANO7 MAIP1 ATP12A CNGA2 CNGA3 ANO3 | 5.99e-05 | 1017 | 117 | 17 | GO:0098660 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1C CACNB3 TRPC7 TRPC3 ADCYAP1R1 DHRS7C PRKACA MAIP1 CNGA2 CNGA3 | 8.04e-05 | 392 | 117 | 10 | GO:0070588 |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 9.32e-05 | 42 | 117 | 4 | GO:0060402 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 1.10e-04 | 191 | 117 | 7 | GO:0006633 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid biosynthetic process | 1.20e-04 | 260 | 117 | 8 | GO:0072330 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1C CACNB3 TRPC7 TRPC3 ADCYAP1R1 SLC32A1 SLC15A1 KCNJ1 DHRS7C PRKACA LRRC8A ANO7 MAIP1 ATP12A CNGA2 CNGA3 ANO3 | 1.82e-04 | 1115 | 117 | 17 | GO:0034220 |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1C TRPC7 ACACA ACACB TRPC3 INSR PTH1R MLXIPL TIAM1 DHRS7C PRKACA PRKACB PRKACG LRRC8A MAIP1 ATP12A HCFC1 ALOX5 | 2.32e-04 | 1249 | 117 | 18 | GO:0048878 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1C CACNB3 TRPC7 TRPC3 MYO1B ADCYAP1R1 SLC32A1 SLC15A1 KCNJ1 DHRS7C PRKACA LRP2 LRRC8A ANO7 MAIP1 ATP12A CNGA2 CNGA3 ANO3 | 2.59e-04 | 1374 | 117 | 19 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 2.90e-04 | 23 | 117 | 3 | GO:0032012 | |
| GeneOntologyBiologicalProcess | calcium activated phospholipid scrambling | 3.15e-04 | 5 | 117 | 2 | GO:0061588 | |
| GeneOntologyBiologicalProcess | calcium activated phosphatidylcholine scrambling | 3.15e-04 | 5 | 117 | 2 | GO:0061590 | |
| GeneOntologyBiologicalProcess | calcium activated galactosylceramide scrambling | 3.15e-04 | 5 | 117 | 2 | GO:0061591 | |
| GeneOntologyBiologicalProcess | arachidonate metabolite production involved in inflammatory response | 3.15e-04 | 5 | 117 | 2 | GO:0002538 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 3.26e-04 | 162 | 117 | 6 | GO:0015748 | |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 3.30e-04 | 24 | 117 | 3 | GO:0032011 | |
| GeneOntologyBiologicalProcess | positive regulation of carbohydrate metabolic process | 3.31e-04 | 105 | 117 | 5 | GO:0045913 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 3.43e-04 | 230 | 117 | 7 | GO:0098739 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 3.46e-04 | 106 | 117 | 5 | GO:0015914 | |
| GeneOntologyBiologicalProcess | renal water homeostasis | 4.20e-04 | 26 | 117 | 3 | GO:0003091 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | ACACA ACACB CMTM2 UBR4 FADS6 PTH1R ADCYAP1R1 MLXIPL PRKACA FADS2 DSEL ALOX5 | 4.63e-04 | 676 | 117 | 12 | GO:0044283 |
| GeneOntologyBiologicalProcess | malonyl-CoA metabolic process | 4.71e-04 | 6 | 117 | 2 | GO:2001293 | |
| GeneOntologyCellularComponent | cAMP-dependent protein kinase complex | 2.26e-05 | 10 | 122 | 3 | GO:0005952 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.81e-04 | 378 | 122 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1C CACNB3 TRPC7 TRPC3 KCNJ1 PRKACA LRRC8A ATP11A ATP12A CNGA2 CNGA3 | 3.82e-04 | 550 | 122 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | cation channel complex | 4.65e-04 | 235 | 122 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | intracellular cyclic nucleotide activated cation channel complex | 6.96e-04 | 7 | 122 | 2 | GO:0017071 | |
| GeneOntologyCellularComponent | cell leading edge | 7.07e-04 | 500 | 122 | 10 | GO:0031252 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 8.81e-04 | 73 | 122 | 4 | GO:0070821 | |
| GeneOntologyCellularComponent | cell projection membrane | 9.70e-04 | 431 | 122 | 9 | GO:0031253 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1C CACNB3 TRPC7 TRPC3 KCNJ1 PRKACA LRRC8A ATP12A CNGA2 CNGA3 | 9.95e-04 | 523 | 122 | 10 | GO:1902495 |
| Domain | PH | DOK1 KIF1A CYTH3 CYTH2 TBC1D2 TIAM2 GAB2 TIAM1 DAPP1 PLD1 PLD2 CADPS2 SKAP2 GAB1 PSD4 | 1.09e-11 | 229 | 115 | 15 | PF00169 |
| Domain | PH | DOK1 KIF1A CYTH3 CYTH2 TBC1D2 TIAM2 GAB2 TIAM1 DAPP1 PLD1 PLD2 CADPS2 SKAP2 GAB1 PSD4 | 1.69e-10 | 278 | 115 | 15 | SM00233 |
| Domain | PH_DOMAIN | DOK1 KIF1A CYTH3 CYTH2 TBC1D2 TIAM2 GAB2 TIAM1 DAPP1 PLD1 PLD2 CADPS2 SKAP2 GAB1 PSD4 | 1.78e-10 | 279 | 115 | 15 | PS50003 |
| Domain | PH_domain | DOK1 KIF1A CYTH3 CYTH2 TBC1D2 TIAM2 GAB2 TIAM1 DAPP1 PLD1 PLD2 CADPS2 SKAP2 GAB1 PSD4 | 1.87e-10 | 280 | 115 | 15 | IPR001849 |
| Domain | PH_dom-like | DOK1 KIF1A CYTH3 CYTH2 TBC1D2 MYO1B TIAM2 GAB2 TIAM1 DAPP1 PLD1 PLD2 CADPS2 SKAP2 GAB1 PSD4 | 7.71e-09 | 426 | 115 | 16 | IPR011993 |
| Domain | - | DOK1 KIF1A CYTH3 CYTH2 TBC1D2 TIAM2 GAB2 TIAM1 DAPP1 PLD1 PLD2 CADPS2 SKAP2 GAB1 PSD4 | 1.78e-08 | 391 | 115 | 15 | 2.30.29.30 |
| Domain | ACC_central | 3.76e-05 | 2 | 115 | 2 | PF08326 | |
| Domain | PLipase_D1/D2 | 3.76e-05 | 2 | 115 | 2 | IPR016555 | |
| Domain | PLipase_D_fam | 3.76e-05 | 2 | 115 | 2 | IPR015679 | |
| Domain | AcCoA_COase_cen | 3.76e-05 | 2 | 115 | 2 | IPR013537 | |
| Domain | - | 9.80e-05 | 15 | 115 | 3 | 1.10.1000.11 | |
| Domain | Sec7 | 9.80e-05 | 15 | 115 | 3 | PF01369 | |
| Domain | Sec7_alpha_orthog | 9.80e-05 | 15 | 115 | 3 | IPR023394 | |
| Domain | PLDc_2 | 1.12e-04 | 3 | 115 | 2 | PF13091 | |
| Domain | PLD-like_dom | 1.12e-04 | 3 | 115 | 2 | IPR025202 | |
| Domain | SEC7 | 1.20e-04 | 16 | 115 | 3 | PS50190 | |
| Domain | Sec7 | 1.20e-04 | 16 | 115 | 3 | SM00222 | |
| Domain | Sec7_dom | 1.20e-04 | 16 | 115 | 3 | IPR000904 | |
| Domain | PLDc | 2.24e-04 | 4 | 115 | 2 | PF00614 | |
| Domain | CLZ | 2.24e-04 | 4 | 115 | 2 | PF16526 | |
| Domain | Carboxyl_trans | 2.24e-04 | 4 | 115 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 2.24e-04 | 4 | 115 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 2.24e-04 | 4 | 115 | 2 | PS50980 | |
| Domain | COA_CT_N | 2.24e-04 | 4 | 115 | 2 | IPR011762 | |
| Domain | COA_CT_C | 2.24e-04 | 4 | 115 | 2 | IPR011763 | |
| Domain | CLZ_dom | 2.24e-04 | 4 | 115 | 2 | IPR032406 | |
| Domain | Carboxyl_trans | 2.24e-04 | 4 | 115 | 2 | IPR000022 | |
| Domain | Biotin_BS | 3.71e-04 | 5 | 115 | 2 | IPR001882 | |
| Domain | Biotin_COase_C | 3.71e-04 | 5 | 115 | 2 | IPR005482 | |
| Domain | BC | 3.71e-04 | 5 | 115 | 2 | PS50979 | |
| Domain | Biotin_carb_C | 3.71e-04 | 5 | 115 | 2 | SM00878 | |
| Domain | Biotin_carb_C | 3.71e-04 | 5 | 115 | 2 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 3.71e-04 | 5 | 115 | 2 | IPR011764 | |
| Domain | CPSASE_1 | 3.71e-04 | 5 | 115 | 2 | PS00866 | |
| Domain | BIOTIN | 3.71e-04 | 5 | 115 | 2 | PS00188 | |
| Domain | AGC-kinase_C | 3.91e-04 | 56 | 115 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.91e-04 | 56 | 115 | 4 | PS51285 | |
| Domain | S_TK_X | 3.91e-04 | 56 | 115 | 4 | SM00133 | |
| Domain | LNS2 | 5.55e-04 | 6 | 115 | 2 | IPR013209 | |
| Domain | TRP_2 | 5.55e-04 | 6 | 115 | 2 | PF08344 | |
| Domain | PI_transfer | 5.55e-04 | 6 | 115 | 2 | IPR001666 | |
| Domain | LNS2 | 5.55e-04 | 6 | 115 | 2 | SM00775 | |
| Domain | DDHD | 5.55e-04 | 6 | 115 | 2 | PF02862 | |
| Domain | DDHD | 5.55e-04 | 6 | 115 | 2 | PS51043 | |
| Domain | DDHD_dom | 5.55e-04 | 6 | 115 | 2 | IPR004177 | |
| Domain | Rudment_hybrid_motif | 5.55e-04 | 6 | 115 | 2 | IPR011054 | |
| Domain | PLDc | 5.55e-04 | 6 | 115 | 2 | SM00155 | |
| Domain | TRP_dom | 5.55e-04 | 6 | 115 | 2 | IPR013555 | |
| Domain | LNS2 | 5.55e-04 | 6 | 115 | 2 | PF08235 | |
| Domain | CPSASE_2 | 5.55e-04 | 6 | 115 | 2 | PS00867 | |
| Domain | LNS2/PITP | 5.55e-04 | 6 | 115 | 2 | IPR031315 | |
| Domain | DDHD | 5.55e-04 | 6 | 115 | 2 | SM01127 | |
| Domain | Ion_trans_dom | 6.98e-04 | 114 | 115 | 5 | IPR005821 | |
| Domain | Ion_trans | 6.98e-04 | 114 | 115 | 5 | PF00520 | |
| Domain | Anoct_dimer | 7.74e-04 | 7 | 115 | 2 | PF16178 | |
| Domain | Anoct_dimer | 7.74e-04 | 7 | 115 | 2 | IPR032394 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 7.74e-04 | 7 | 115 | 2 | IPR005479 | |
| Domain | BC-like_N | 7.74e-04 | 7 | 115 | 2 | IPR005481 | |
| Domain | TRPC_channel | 7.74e-04 | 7 | 115 | 2 | IPR002153 | |
| Domain | RBD | 7.74e-04 | 7 | 115 | 2 | SM00455 | |
| Domain | PLipase_D/transphosphatidylase | 7.74e-04 | 7 | 115 | 2 | IPR001736 | |
| Domain | CPSase_L_D2 | 7.74e-04 | 7 | 115 | 2 | PF02786 | |
| Domain | PLD | 7.74e-04 | 7 | 115 | 2 | PS50035 | |
| Domain | Biotin_carb_N | 7.74e-04 | 7 | 115 | 2 | PF00289 | |
| Domain | RBD_dom | 7.74e-04 | 7 | 115 | 2 | IPR003116 | |
| Domain | RBD | 7.74e-04 | 7 | 115 | 2 | PS50898 | |
| Domain | ATP_grasp_subdomain_2 | 9.01e-04 | 31 | 115 | 3 | IPR013816 | |
| Domain | FA_desaturase_dom | 1.03e-03 | 8 | 115 | 2 | IPR005804 | |
| Domain | FA_desaturase | 1.03e-03 | 8 | 115 | 2 | PF00487 | |
| Domain | Biotin_lipoyl | 1.32e-03 | 9 | 115 | 2 | PF00364 | |
| Domain | HAD-like_dom | 1.44e-03 | 79 | 115 | 4 | IPR023214 | |
| Domain | Anoctamin | 1.64e-03 | 10 | 115 | 2 | PF04547 | |
| Domain | Anoctamin | 1.64e-03 | 10 | 115 | 2 | IPR007632 | |
| Domain | BIOTINYL_LIPOYL | 1.64e-03 | 10 | 115 | 2 | PS50968 | |
| Domain | Biotin_lipoyl | 1.64e-03 | 10 | 115 | 2 | IPR000089 | |
| Domain | TRP_channel | 1.99e-03 | 11 | 115 | 2 | IPR004729 | |
| Domain | Single_hybrid_motif | 2.38e-03 | 12 | 115 | 2 | IPR011053 | |
| Domain | PX | 2.51e-03 | 44 | 115 | 3 | SM00312 | |
| Domain | - | 2.80e-03 | 13 | 115 | 2 | 3.40.50.20 | |
| Domain | CYTOCHROME_B5_2 | 2.80e-03 | 13 | 115 | 2 | PS50255 | |
| Domain | CYTOCHROME_B5_1 | 2.80e-03 | 13 | 115 | 2 | PS00191 | |
| Domain | Cyt-b5 | 3.26e-03 | 14 | 115 | 2 | PF00173 | |
| Domain | - | 3.26e-03 | 14 | 115 | 2 | 3.10.120.10 | |
| Domain | ATP_GRASP | 3.26e-03 | 14 | 115 | 2 | PS50975 | |
| Domain | ATP-grasp | 3.26e-03 | 14 | 115 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 3.26e-03 | 14 | 115 | 2 | IPR016185 | |
| Domain | Cyt_B5-like_heme/steroid-bd | 3.26e-03 | 14 | 115 | 2 | IPR001199 | |
| Domain | Cyt-b5 | 3.26e-03 | 14 | 115 | 2 | SM01117 | |
| Domain | PX | 3.41e-03 | 49 | 115 | 3 | PF00787 | |
| Domain | PX | 3.61e-03 | 50 | 115 | 3 | PS50195 | |
| Domain | PI3/4_kinase_CS | 3.74e-03 | 15 | 115 | 2 | IPR018936 | |
| Domain | - | 3.74e-03 | 15 | 115 | 2 | 3.30.1490.20 | |
| Domain | - | 3.82e-03 | 51 | 115 | 3 | 3.30.1520.10 | |
| Domain | Phox | 4.04e-03 | 52 | 115 | 3 | IPR001683 | |
| Domain | cNMP-bd_CS | 4.26e-03 | 16 | 115 | 2 | IPR018488 | |
| Domain | - | 4.26e-03 | 16 | 115 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.26e-03 | 16 | 115 | 2 | SM00146 | |
| Domain | ATP_grasp_subdomain_1 | 5.39e-03 | 18 | 115 | 2 | IPR013815 | |
| Domain | PI3_PI4_kinase | 5.39e-03 | 18 | 115 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.39e-03 | 18 | 115 | 2 | PS00915 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 7.39e-09 | 5 | 89 | 4 | M26988 | |
| Pathway | REACTOME_RET_SIGNALING | 1.72e-07 | 40 | 89 | 6 | M27746 | |
| Pathway | REACTOME_ROBO_RECEPTORS_BIND_AKAP5 | 1.83e-07 | 9 | 89 | 4 | M27877 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.86e-07 | 108 | 89 | 8 | M17034 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 1.92e-06 | 15 | 89 | 4 | M47504 | |
| Pathway | WP_RAS_SIGNALING | 2.34e-06 | 184 | 89 | 9 | M39764 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 8.36e-06 | 7 | 89 | 3 | M47896 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 1.33e-05 | 8 | 89 | 3 | M27840 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 1.33e-05 | 8 | 89 | 3 | M26991 | |
| Pathway | PID_IL3_PATHWAY | 2.00e-05 | 26 | 89 | 4 | M182 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 2.83e-05 | 10 | 89 | 3 | M47648 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 3.12e-05 | 29 | 89 | 4 | M39762 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 4.19e-05 | 101 | 89 | 6 | M1979 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 5.14e-05 | 12 | 89 | 3 | M27950 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 5.14e-05 | 12 | 89 | 3 | M27363 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | DOK1 CACNA1C CACNB3 TRPC7 TRPC3 GAB2 GSPT1 TIAM1 PRKACA PRKACB PRKACG ROBO2 GAB1 | 6.16e-05 | 575 | 89 | 13 | M29853 |
| Pathway | WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING | 6.36e-05 | 67 | 89 | 5 | M39630 | |
| Pathway | WP_DOPAMINE_METABOLISM | 6.65e-05 | 13 | 89 | 3 | M39622 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | ACACA ACACB TIAM2 PITPNM1 PIK3C2B PRKACA PRKACB PRKACG HELZ2 PITPNM3 LRP2 FADS2 PLD1 PLD2 ALOX5 | 7.18e-05 | 757 | 89 | 15 | M27451 |
| Pathway | PID_GMCSF_PATHWAY | 7.49e-05 | 36 | 89 | 4 | M22 | |
| Pathway | REACTOME_RET_SIGNALING | 9.30e-05 | 38 | 89 | 4 | MM15493 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.05e-04 | 15 | 89 | 3 | M47794 | |
| Pathway | PID_ARF6_DOWNSTREAM_PATHWAY | 1.05e-04 | 15 | 89 | 3 | M120 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 1.28e-04 | 16 | 89 | 3 | M47551 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 1.28e-04 | 16 | 89 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 1.28e-04 | 16 | 89 | 3 | M47650 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 1.28e-04 | 16 | 89 | 3 | M923 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.32e-04 | 78 | 89 | 5 | M1921 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 1.52e-04 | 43 | 89 | 4 | M39706 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 1.55e-04 | 17 | 89 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.55e-04 | 17 | 89 | 3 | M47544 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 2.19e-04 | 19 | 89 | 3 | M27841 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 2.19e-04 | 19 | 89 | 3 | M22004 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 2.26e-04 | 137 | 89 | 6 | M18155 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.57e-04 | 20 | 89 | 3 | M759 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 2.58e-04 | 90 | 89 | 5 | M835 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 2.98e-04 | 21 | 89 | 3 | M27485 | |
| Pathway | WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM | 3.89e-04 | 5 | 89 | 2 | M48057 | |
| Pathway | REACTOME_SYNTHESIS_OF_PI | 3.89e-04 | 5 | 89 | 2 | M26962 | |
| Pathway | REACTOME_SYNTHESIS_OF_PI | 3.89e-04 | 5 | 89 | 2 | MM14587 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 4.24e-04 | 56 | 89 | 4 | M1053 | |
| Pathway | REACTOME_TRIGLYCERIDE_CATABOLISM | 4.47e-04 | 24 | 89 | 3 | M10064 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 4.47e-04 | 24 | 89 | 3 | M47520 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 4.47e-04 | 24 | 89 | 3 | M751 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 5.69e-04 | 26 | 89 | 3 | M47553 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 5.82e-04 | 6 | 89 | 2 | MM14628 | |
| Pathway | WP_METABOLISM_OF_ALPHALINOLENIC_ACID | 5.82e-04 | 6 | 89 | 2 | M39844 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 5.89e-04 | 61 | 89 | 4 | MM15071 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 6.38e-04 | 27 | 89 | 3 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 6.38e-04 | 27 | 89 | 3 | M47519 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPC7 TRPC3 SLC32A1 SLC15A1 PRKACA PRKACB PRKACG LRRC8A ANO7 MAIP1 ATP11A ATP12A ANO3 | 6.88e-04 | 736 | 89 | 13 | M27287 |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 7.11e-04 | 28 | 89 | 3 | M47647 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 7.89e-04 | 29 | 89 | 3 | M47627 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 7.89e-04 | 29 | 89 | 3 | M39676 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 7.89e-04 | 29 | 89 | 3 | M47515 | |
| Pathway | BIOCARTA_CB1R_PATHWAY | 8.11e-04 | 7 | 89 | 2 | MM1569 | |
| Pathway | BIOCARTA_CB1R_PATHWAY | 8.11e-04 | 7 | 89 | 2 | M22054 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 8.11e-04 | 7 | 89 | 2 | MM15560 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 8.58e-04 | 176 | 89 | 6 | MM15718 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 8.73e-04 | 30 | 89 | 3 | M42578 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 8.73e-04 | 30 | 89 | 3 | M47738 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 9.62e-04 | 31 | 89 | 3 | M47507 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 9.91e-04 | 70 | 89 | 4 | M3115 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.05e-03 | 183 | 89 | 6 | M997 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.06e-03 | 32 | 89 | 3 | M47506 | |
| Pathway | REACTOME_SYNTHESIS_OF_PG | 1.08e-03 | 8 | 89 | 2 | M26961 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.08e-03 | 184 | 89 | 6 | M41809 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.10e-03 | 72 | 89 | 4 | MM14631 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPC7 TRPC3 SLC32A1 SLC15A1 PRKACA PRKACB LRRC8A ANO7 MAIP1 ATP11A ATP12A ANO3 | 1.15e-03 | 681 | 89 | 12 | MM14985 |
| Pathway | WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN | 1.16e-03 | 33 | 89 | 3 | M48071 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 1.16e-03 | 33 | 89 | 3 | M39532 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 1.16e-03 | 33 | 89 | 3 | M11575 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.21e-03 | 188 | 89 | 6 | MM15828 | |
| Pathway | KEGG_PRION_DISEASES | 1.38e-03 | 35 | 89 | 3 | M13036 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.38e-03 | 35 | 89 | 3 | M47969 | |
| Pathway | WP_BIOTIN_METABOLISM_INCLUDING_IMDS | 1.38e-03 | 9 | 89 | 2 | M40064 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 1.49e-03 | 36 | 89 | 3 | M1315 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.62e-03 | 37 | 89 | 3 | M749 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 1.72e-03 | 10 | 89 | 2 | MM1530 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 1.72e-03 | 10 | 89 | 2 | M27330 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS | 1.72e-03 | 10 | 89 | 2 | M47930 | |
| Pathway | REACTOME_TRIGLYCERIDE_METABOLISM | 1.75e-03 | 38 | 89 | 3 | M27856 | |
| Pathway | PID_RET_PATHWAY | 1.89e-03 | 39 | 89 | 3 | M82 | |
| Pathway | BIOCARTA_AKAP95_PATHWAY | 2.09e-03 | 11 | 89 | 2 | M5731 | |
| Pathway | BIOCARTA_PLCE_PATHWAY | 2.09e-03 | 11 | 89 | 2 | M5576 | |
| Pathway | BIOCARTA_CFTR_PATHWAY | 2.09e-03 | 11 | 89 | 2 | M12399 | |
| Pathway | BIOCARTA_AGPCR_PATHWAY | 2.09e-03 | 11 | 89 | 2 | M19829 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 2.09e-03 | 11 | 89 | 2 | M17668 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 2.09e-03 | 11 | 89 | 2 | M27086 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 2.09e-03 | 11 | 89 | 2 | MM14764 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 2.18e-03 | 41 | 89 | 3 | M39655 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.18e-03 | 41 | 89 | 3 | M512 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 2.20e-03 | 367 | 89 | 8 | M48346 | |
| Pathway | PID_TCPTP_PATHWAY | 2.34e-03 | 42 | 89 | 3 | M91 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 2.34e-03 | 42 | 89 | 3 | M27172 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 2.34e-03 | 42 | 89 | 3 | M791 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 2.50e-03 | 12 | 89 | 2 | MM1342 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.50e-03 | 12 | 89 | 2 | M7968 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 2.50e-03 | 43 | 89 | 3 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 2.50e-03 | 43 | 89 | 3 | M933 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 2342480 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 19383776 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 12842892 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 18385332 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 12721358 | ||
| Pubmed | HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction. | 4.19e-07 | 5 | 122 | 3 | 21745501 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 12972513 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 19483721 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 9540970 | ||
| Pubmed | PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity. | 4.19e-07 | 5 | 122 | 3 | 19711044 | |
| Pubmed | Architectural DNA-binding properties of the spermatidal transition proteins 1 and 2. | 8.36e-07 | 6 | 122 | 3 | 9837753 | |
| Pubmed | Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. | 8.36e-07 | 6 | 122 | 3 | 19197368 | |
| Pubmed | 1.46e-06 | 7 | 122 | 3 | 14982882 | ||
| Pubmed | 1.46e-06 | 7 | 122 | 3 | 16407073 | ||
| Pubmed | Phosphorylation of HIV Nef by cAMP-dependent protein kinase. | 1.46e-06 | 7 | 122 | 3 | 15629779 | |
| Pubmed | CCL3L1 prevents gp120-induced neuron death via the CREB cell signaling pathway. | 2.33e-06 | 8 | 122 | 3 | 19100722 | |
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 12628924 | ||
| Pubmed | 3.48e-06 | 9 | 122 | 3 | 7688126 | ||
| Pubmed | HIV-1 Tat-peptide inhibits protein kinase C and protein kinase A through substrate competition. | 4.96e-06 | 10 | 122 | 3 | 20433920 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ACACA CYTH3 UBR4 GEMIN5 SFI1 REV3L MLXIP LARS2 TIAM2 MST1R PIK3C2B HELZ2 HERC2 HCFC1 ALOX5 | 7.97e-06 | 1105 | 122 | 15 | 35748872 |
| Pubmed | 9.05e-06 | 12 | 122 | 3 | 10830164 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 9.70e-06 | 38 | 122 | 4 | 30786075 | |
| Pubmed | Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. | 1.17e-05 | 13 | 122 | 3 | 18836454 | |
| Pubmed | 1.17e-05 | 13 | 122 | 3 | 19895210 | ||
| Pubmed | The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells. | 1.17e-05 | 13 | 122 | 3 | 20402410 | |
| Pubmed | 1.17e-05 | 13 | 122 | 3 | 20392842 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9813240 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 32814056 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 30369483 | ||
| Pubmed | Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. | 1.22e-05 | 2 | 122 | 2 | 3023318 | |
| Pubmed | Differential regulation of apoptosis by caspase-mediated cleavage of phospholipase D isozymes. | 1.22e-05 | 2 | 122 | 2 | 18694819 | |
| Pubmed | Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models. | 1.22e-05 | 2 | 122 | 2 | 32661773 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24618697 | ||
| Pubmed | Phospholipase D is essential for keratocyte-like migration of NBT-II cells. | 1.22e-05 | 2 | 122 | 2 | 18344600 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24944901 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12615079 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 36362078 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23822091 | ||
| Pubmed | Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. | 1.22e-05 | 2 | 122 | 2 | 20139635 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 28081256 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20188462 | ||
| Pubmed | Organization and alternative splicing of the murine phospholipase D2 gene. | 1.22e-05 | 2 | 122 | 2 | 9560313 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26976583 | ||
| Pubmed | Phospholipase D1 Ablation Disrupts Mouse Longitudinal Hippocampal Axis Organization and Functioning. | 1.22e-05 | 2 | 122 | 2 | 32209478 | |
| Pubmed | Cross-talk between phospholipase D and MAP kinases activities. | 1.22e-05 | 2 | 122 | 2 | 19896495 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15952937 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21760893 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23868933 | ||
| Pubmed | MondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic β-Cells. | 1.22e-05 | 2 | 122 | 2 | 29282201 | |
| Pubmed | Phospholipase D isoforms differentially regulate leukocyte responses to acute lung injury. | 1.22e-05 | 2 | 122 | 2 | 29437245 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9582313 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 36152045 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 38841868 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 34610470 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 33069962 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 33368247 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 28075014 | ||
| Pubmed | The phospholipase D pathway mediates the inflammatory response of the retinal pigment epithelium. | 1.22e-05 | 2 | 122 | 2 | 25172550 | |
| Pubmed | Endogenous Fatty Acid Synthesis Drives Brown Adipose Tissue Involution. | 1.22e-05 | 2 | 122 | 2 | 33440156 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 14550769 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 37455419 | ||
| Pubmed | Phospholipase D1 and D2 Synergistically Regulate Thrombus Formation. | 1.22e-05 | 2 | 122 | 2 | 32971863 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19707939 | ||
| Pubmed | Molecular and behavioral effects of a null mutation in all PKA C beta isoforms. | 1.22e-05 | 2 | 122 | 2 | 12139926 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25001074 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 31090437 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9247274 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 2833513 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 10677481 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 29123182 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24338821 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18997336 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18432522 | ||
| Pubmed | Combined detection of Gab1 and Gab2 expression predicts clinical outcome of patients with glioma. | 1.22e-05 | 2 | 122 | 2 | 24998422 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18829456 | ||
| Pubmed | De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. | 1.22e-05 | 2 | 122 | 2 | 25282359 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27693630 | ||
| Pubmed | Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2. | 1.22e-05 | 2 | 122 | 2 | 16873675 | |
| Pubmed | Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. | 1.22e-05 | 2 | 122 | 2 | 16644671 | |
| Pubmed | Generation of choline for acetylcholine synthesis by phospholipase D isoforms. | 1.22e-05 | 2 | 122 | 2 | 11734063 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23383154 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 32215608 | ||
| Pubmed | Characterization of human PLD2 and the analysis of PLD isoform splice variants. | 1.22e-05 | 2 | 122 | 2 | 9761774 | |
| Pubmed | The molecular basis of leukocyte adhesion involving phosphatidic acid and phospholipase D. | 1.22e-05 | 2 | 122 | 2 | 25187519 | |
| Pubmed | Phospholipase D in TCR-Mediated Signaling and T Cell Activation. | 1.22e-05 | 2 | 122 | 2 | 29386256 | |
| Pubmed | Global consequences of activation loop phosphorylation on protein kinase A. | 1.22e-05 | 2 | 122 | 2 | 19965870 | |
| Pubmed | Activity and structure of human acetyl-CoA carboxylase targeted by a specific inhibitor. | 1.22e-05 | 2 | 122 | 2 | 29772612 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 29976587 | ||
| Pubmed | Phospholipase D1 is a regulator of platelet-mediated inflammation. | 1.22e-05 | 2 | 122 | 2 | 28711718 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20711340 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15039079 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27522668 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26910886 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23131846 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 30207376 | ||
| Pubmed | Redundant functions of phospholipases D1 and D2 in platelet α-granule release. | 1.22e-05 | 2 | 122 | 2 | 22974101 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12180908 | ||
| Pubmed | Phospholipase D is a target for inhibition of astroglial proliferation by ethanol. | 1.22e-05 | 2 | 122 | 2 | 24262632 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23698760 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24103483 | ||
| Interaction | PLCG1 interactions | 3.53e-06 | 264 | 118 | 10 | int:PLCG1 | |
| Interaction | FKBP5 interactions | REXO5 ATR RADX SRMS GEMIN5 AHSA1 PRKACA PRKACB PRKACG PKN2 PLD2 HCFC1 | 5.78e-06 | 414 | 118 | 12 | int:FKBP5 |
| Interaction | SRC interactions | DOK1 MICAL1 INSR SRMS TIAM2 GAB2 MST1R TIAM1 PRKACA DAPP1 USP4 PLD1 PLD2 SKAP2 GAB1 | 7.82e-06 | 664 | 118 | 15 | int:SRC |
| Interaction | CETN1 interactions | 3.39e-05 | 63 | 118 | 5 | int:CETN1 | |
| Interaction | PKIG interactions | 4.14e-05 | 12 | 118 | 3 | int:PKIG | |
| Interaction | TNP1 interactions | 4.14e-05 | 12 | 118 | 3 | int:TNP1 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | KIF1A CYTH3 CYTH2 TIAM2 GAB2 TIAM1 DAPP1 PLD1 CADPS2 SKAP2 GAB1 PSD4 | 3.82e-10 | 206 | 89 | 12 | 682 |
| GeneFamily | Phosphatidylinositol transfer proteins | 3.55e-04 | 6 | 89 | 2 | 1151 | |
| GeneFamily | Fatty acid desaturases | 6.58e-04 | 8 | 89 | 2 | 553 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.05e-03 | 10 | 89 | 2 | 250 | |
| GeneFamily | Anoctamins | 1.05e-03 | 10 | 89 | 2 | 865 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-08 | 192 | 122 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 184 | 122 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 184 | 122 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 184 | 122 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.06e-06 | 193 | 122 | 7 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.11e-06 | 159 | 122 | 6 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.25e-06 | 169 | 122 | 6 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.28e-06 | 173 | 122 | 6 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.56e-06 | 174 | 122 | 6 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.11e-05 | 182 | 122 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.21e-05 | 185 | 122 | 6 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 1.33e-05 | 188 | 122 | 6 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.33e-05 | 188 | 122 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.37e-05 | 189 | 122 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | distal-Hematologic-Platelet/Megakaryocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.73e-05 | 197 | 122 | 6 | 751ffb8792058384079ebfe94872b3525f1aea84 | |
| ToppCell | distal-Hematologic-Platelet/Megakaryocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.73e-05 | 197 | 122 | 6 | e28b1b154d9588dce07c123b36f7f01fa90a5fc1 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-05 | 197 | 122 | 6 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 198 | 122 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 200 | 122 | 6 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 200 | 122 | 6 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-Dividing_AT2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 200 | 122 | 6 | befc25cbcbac2c02e5fd33d6e78e59979050090c | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 125 | 122 | 5 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.06e-05 | 131 | 122 | 5 | d5bc40cd585582856881081b7130dec3515b4ae0 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 131 | 122 | 5 | 419a0a83b38eaea890d065c3f252ef83c2d37b5b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Nonmucinous_Lepidic_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.65e-05 | 143 | 122 | 5 | 510e0410544f78ebc5bb597e87f01a00ce48b39b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 156 | 122 | 5 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 156 | 122 | 5 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 156 | 122 | 5 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | Healthy/Control-CD8+_T_naive|World / Disease group and Cell class | 7.46e-05 | 158 | 122 | 5 | 70680b29428b6bf882b1fae36f924b775961176b | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.46e-05 | 158 | 122 | 5 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Mast-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.69e-05 | 159 | 122 | 5 | 81782e9e370558d61af5e0c760ac9759d69fb725 | |
| ToppCell | facs-BAT-Fat-24m-Myeloid|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 166 | 122 | 5 | 001a31aaa4ab4d5606b894faf6fcaad524405064 | |
| ToppCell | facs-BAT-Fat-24m-Myeloid-myeloid_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 166 | 122 | 5 | 31ed1290b4a977eabfc29674a5c593985bff6a74 | |
| ToppCell | facs-BAT-Fat-24m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 166 | 122 | 5 | c71ad3fc6a14507609d17756431d3deff9fda418 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-04 | 169 | 122 | 5 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 169 | 122 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 170 | 122 | 5 | d72eb77271d61e27a3d247149561c7f45fadb28b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 170 | 122 | 5 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.08e-04 | 171 | 122 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 171 | 122 | 5 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | Control-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 1.11e-04 | 172 | 122 | 5 | 813d4256b05b66ca11b08cc0026459d79f12c0eb | |
| ToppCell | FLU-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 1.14e-04 | 173 | 122 | 5 | 8c218ec1ba927e9312f3df5f312395e907ab64ab | |
| ToppCell | TCGA-Brain-Primary_Tumor|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.14e-04 | 173 | 122 | 5 | f6ba22661e67c17d49d1058d4170ba8f36bf47f0 | |
| ToppCell | FLU-Healthy-5|FLU / Virus stimulation, Condition and Cluster | 1.14e-04 | 173 | 122 | 5 | bd4f06d971f9d138749094047c9337dfbaf5da31 | |
| ToppCell | Control-Stromal-Pericyte|Control / Disease state, Lineage and Cell class | 1.17e-04 | 174 | 122 | 5 | 91fc1f1c891f105a91968c22e2de5321c52b439a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 176 | 122 | 5 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 176 | 122 | 5 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-04 | 177 | 122 | 5 | d5503605d46a335cc7ca1f94626809f9e1b505e2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 178 | 122 | 5 | a62137d7f5fac16619f8a02844cdb0be7a794bf2 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 179 | 122 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 179 | 122 | 5 | c7f3aeef6bc4cfbbe5c8a8d7877b86cef23d4692 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 180 | 122 | 5 | fd8c2059fcb382ffbfe19e598e37a49e1d5637b5 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-04 | 180 | 122 | 5 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 180 | 122 | 5 | a407376209d80177bf7fc4200219030c83cb5f14 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.41e-04 | 181 | 122 | 5 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.41e-04 | 181 | 122 | 5 | 8fcc9e77fee7c248df26b6c59b10e672242e2084 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 181 | 122 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.45e-04 | 182 | 122 | 5 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 1.45e-04 | 182 | 122 | 5 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 1.49e-04 | 183 | 122 | 5 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 1.49e-04 | 183 | 122 | 5 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | PND07-28-samps-Epithelial-Alveolar_epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.49e-04 | 183 | 122 | 5 | 23e55f88a802a9299d2773f9394970e86e8bbfaa | |
| ToppCell | PND07-28-samps-Epithelial-Alveolar_epithelial-AT2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.49e-04 | 183 | 122 | 5 | 0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 1.49e-04 | 183 | 122 | 5 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.56e-04 | 185 | 122 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 185 | 122 | 5 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.56e-04 | 185 | 122 | 5 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 1.56e-04 | 185 | 122 | 5 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-04 | 185 | 122 | 5 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.56e-04 | 185 | 122 | 5 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-04 | 185 | 122 | 5 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-04 | 185 | 122 | 5 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 186 | 122 | 5 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 186 | 122 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 1.60e-04 | 186 | 122 | 5 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | 3'_v3-blood-Hematopoietic_progenitors-Progenitor_Erythro-Mega|blood / Manually curated celltypes from each tissue | 1.60e-04 | 186 | 122 | 5 | 59c115bbbb4bca4ad80be1809d8a0422b8438ea3 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 186 | 122 | 5 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-04 | 187 | 122 | 5 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.64e-04 | 187 | 122 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-04 | 187 | 122 | 5 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.69e-04 | 188 | 122 | 5 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 1.69e-04 | 188 | 122 | 5 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-04 | 190 | 122 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-04 | 190 | 122 | 5 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 190 | 122 | 5 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 191 | 122 | 5 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 192 | 122 | 5 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.90e-04 | 193 | 122 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 193 | 122 | 5 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-04 | 193 | 122 | 5 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 193 | 122 | 5 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-04 | 193 | 122 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 193 | 122 | 5 | 1526f51b589a7dc7a28f35f0e788dc38d338d2bc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 193 | 122 | 5 | d994b2f2707877288f88cab7cd6002ef91962c50 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.90e-04 | 193 | 122 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 193 | 122 | 5 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 194 | 122 | 5 | 8f19e553f18c313c2a2ff9453884b9484b255d71 | |
| ToppCell | severe-Myeloid-Neutrophils_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.95e-04 | 194 | 122 | 5 | 1f8edab1c8ba48bc0114429ea47aab378b5830b7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.95e-04 | 194 | 122 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 194 | 122 | 5 | 67fbb81b7d20cb63be27b2a2beea5b5689f8e08c | |
| Drug | myo-inositol | DOK1 CACNA1C CACNB3 ACACA CYTH3 TRPC3 INSR SRMS PTH1R ADCYAP1R1 GAB2 PIK3C2B PRKACA PRKACB PRKACG PKN2 ATP11A PLD1 PLD2 DSEL ALOX5 GAB1 | 2.86e-10 | 811 | 121 | 22 | CID000000892 |
| Drug | AC1OAGKW | CYTH3 CYTH2 INSR GAB2 PITPNM1 PIK3C2B DAPP1 LRP2 PKN2 PLD1 PLD2 GAB1 | 5.11e-10 | 193 | 121 | 12 | CID006857413 |
| Drug | AC1L1BDQ | TRPC7 TRPC3 INSR ADCYAP1R1 PRKACA PRKACB PRKACG PKN2 PLD1 PLD2 ALOX5 | 2.20e-09 | 173 | 121 | 11 | CID000001394 |
| Drug | 8-Br | 1.55e-07 | 156 | 121 | 9 | CID000168120 | |
| Drug | H 85 | 2.35e-07 | 26 | 121 | 5 | CID006439306 | |
| Drug | AC1L1KS5 | CACNA1C CACNB3 TRPC3 PTH1R ADCYAP1R1 TIAM1 PRKACA PRKACB PRKACG PLD1 PLD2 | 1.75e-06 | 334 | 121 | 11 | CID000005631 |
| Drug | lavendustin A | 3.76e-06 | 171 | 121 | 8 | CID000003894 | |
| Drug | NPC 15437 | 4.49e-06 | 46 | 121 | 5 | CID000004548 | |
| Drug | Go6976 | 8.17e-06 | 190 | 121 | 8 | CID000003501 | |
| Drug | 7B-forskolin | 1.04e-05 | 26 | 121 | 4 | CID000130638 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA1C CACNB3 TRPC7 CYTH3 TRPC3 SRMS MST1R PRKACA PRKACB PRKACG PKN2 PLD1 PLD2 | 1.06e-05 | 568 | 121 | 13 | CID000000806 |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 10uM; PC3; HT_HG-U133A | 1.10e-05 | 198 | 121 | 8 | 3824_UP | |
| Drug | SecinH3 | 1.20e-05 | 9 | 121 | 3 | CID001029232 | |
| Drug | agrocin 84 | 1.71e-05 | 10 | 121 | 3 | CID003035458 | |
| Drug | Phosphoryl | 2.00e-05 | 215 | 121 | 8 | CID006857426 | |
| Drug | phosphine oxide | 2.32e-05 | 107 | 121 | 6 | CID000166931 | |
| Drug | AC1O4QHT | 2.34e-05 | 11 | 121 | 3 | CID006398429 | |
| Drug | wartmannin | CYTH3 INSR SRMS MYO1B GAB2 MST1R TIAM1 PIK3C2B PRKACA PRKACB PRKACG PKN2 PLD1 PLD2 GAB1 | 2.67e-05 | 811 | 121 | 15 | CID000005691 |
| Drug | MDL-12330A | 2.69e-05 | 66 | 121 | 5 | CID000004024 | |
| Drug | isosteviol | 3.11e-05 | 12 | 121 | 3 | ctd:C515747 | |
| Drug | AC1L1KC5 | CACNA1C CACNB3 TRPC7 TRPC3 ADCYAP1R1 PRKACA PRKACB PRKACG PLD1 PLD2 CNGA2 ALOX5 | 3.20e-05 | 541 | 121 | 12 | CID000005428 |
| Drug | myristate | 4.26e-05 | 310 | 121 | 9 | CID000011005 | |
| Drug | (2S,3R)-Sphingosine | TRHDE INSR TIAM1 PIK3C2B PRKACA PRKACB PRKACG PKN2 PLD1 PLD2 | 4.44e-05 | 389 | 121 | 10 | CID000001104 |
| Drug | 8-N3cAMP | 5.11e-05 | 14 | 121 | 3 | CID006426627 | |
| Drug | 8-(6-aminohexyl)amino cyclic AMP | 5.11e-05 | 14 | 121 | 3 | CID000161999 | |
| Drug | glycylglycylglycine | 5.98e-05 | 40 | 121 | 4 | CID000011161 | |
| Drug | trifluoperazine | 5.99e-05 | 324 | 121 | 9 | CID000005566 | |
| Drug | NA-382 | 6.36e-05 | 15 | 121 | 3 | CID000132534 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 7.15e-05 | 190 | 121 | 7 | 2700_UP | |
| Drug | GTP[S] | CACNA1C MGAM CACNB3 INSR PTH1R KCNJ1 PRKACA PRKACB PRKACG PKN2 PLD1 PLD2 | 7.49e-05 | 591 | 121 | 12 | CID000001764 |
| Drug | carbachol | CACNA1C CACNB3 TRPC7 TRPC3 SRMS PIK3C2B KCNJ1 PRKACA PRKACB PRKACG PKN2 PLD1 PLD2 | 7.69e-05 | 688 | 121 | 13 | CID000002551 |
| Drug | phorbol 12-myristate | 7.90e-05 | 261 | 121 | 8 | CID000107854 | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 8.15e-05 | 194 | 121 | 7 | 7221_DN | |
| Drug | Roxithromycin [80214-83-1]; Down 200; 4.8uM; PC3; HT_HG-U133A | 8.15e-05 | 194 | 121 | 7 | 4192_DN | |
| Drug | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 8.37e-05 | 3 | 121 | 2 | DB03909 | |
| Drug | calcium carbonate phosphate | 8.37e-05 | 3 | 121 | 2 | CID006337635 | |
| Drug | 2-(hydroxymethyl)-1,4-benzodioxan | 8.37e-05 | 3 | 121 | 2 | CID000019314 | |
| Drug | sialylphospholipid | 8.37e-05 | 3 | 121 | 2 | CID000515706 | |
| Drug | N,N'-diethylethylenediamine | 8.37e-05 | 3 | 121 | 2 | CID000067105 | |
| Drug | PF-00875133-00 [351322-64-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 5967_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 1532_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; PC3; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 6760_DN | |
| Drug | rottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 8.69e-05 | 196 | 121 | 7 | 825_UP | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 3374_DN | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; PC3; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 7155_UP | |
| Drug | Cytisine (-) [485-35-8]; Up 200; 21uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 2759_UP | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 5076_UP | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 2766_UP | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 4551_DN | |
| Drug | DNA-PK Inhibitor III; Up 200; 1uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 7513_UP | |
| Drug | AC1OAGKB | 9.26e-05 | 198 | 121 | 7 | CID006857406 | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 4425_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 3344_DN | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 2635_UP | |
| Drug | AH6809 | 9.55e-05 | 45 | 121 | 4 | CID000119461 | |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A | 9.85e-05 | 200 | 121 | 7 | 7308_DN | |
| Drug | calphostin C | PTH1R ADCYAP1R1 KCNJ1 PRKACA PRKACB PRKACG PKN2 PLD1 PLD2 ALOX5 | 1.04e-04 | 431 | 121 | 10 | CID000002533 |
| Drug | K 252 | 1.07e-04 | 88 | 121 | 5 | CID000003813 | |
| Drug | phosphotyrosine (pY | 1.08e-04 | 203 | 121 | 7 | CID000030819 | |
| Drug | 8-azido cyclic AMP | 1.13e-04 | 18 | 121 | 3 | CID000115296 | |
| Drug | AC1Q6RZL | 1.13e-04 | 47 | 121 | 4 | CID000001144 | |
| Drug | AC1L9HHR | 1.18e-04 | 354 | 121 | 9 | CID000445141 | |
| Drug | 1,3-diolein | 1.20e-04 | 90 | 121 | 5 | CID000033120 | |
| Drug | DiC8 | 1.32e-04 | 146 | 121 | 6 | CID000001323 | |
| Drug | 8-azidoadenosine | 1.33e-04 | 19 | 121 | 3 | CID000160751 | |
| Drug | 8-thiomethyl-cAMP | 1.33e-04 | 19 | 121 | 3 | CID000093140 | |
| Drug | Starlicide | 1.34e-04 | 49 | 121 | 4 | CID000007255 | |
| Drug | Zm 241385 | 1.34e-04 | 49 | 121 | 4 | CID000176407 | |
| Drug | BiM4 | 1.38e-04 | 283 | 121 | 8 | CID000002399 | |
| Drug | 1,3-DCG | 1.47e-04 | 94 | 121 | 5 | CID000150911 | |
| Drug | glucose-6-P | 1.51e-04 | 366 | 121 | 9 | CID000000208 | |
| Drug | mercury | CACNA1C MGAM CACNB3 SRMS MYO1B CPB1 LARS2 F5 PIK3C2B MYOM2 DNMT3A | 1.52e-04 | 542 | 121 | 11 | CID000023931 |
| Drug | Bay K 8644 | 1.53e-04 | 150 | 121 | 6 | CID000002303 | |
| Drug | milrinone | 1.53e-04 | 150 | 121 | 6 | CID000004197 | |
| Drug | tolazamide | 1.56e-04 | 20 | 121 | 3 | CID000005503 | |
| Drug | YM435 | 1.56e-04 | 20 | 121 | 3 | CID000132119 | |
| Drug | carbodiimide | 1.58e-04 | 151 | 121 | 6 | CID000009864 | |
| Drug | O148 | 1.67e-04 | 4 | 121 | 2 | CID000078219 | |
| Drug | 2-naphthylbenzothiazole | 1.67e-04 | 4 | 121 | 2 | CID011585872 | |
| Drug | Froxiprostum | 1.67e-04 | 4 | 121 | 2 | CID006434698 | |
| Drug | 9-hexadecenal | 1.67e-04 | 4 | 121 | 2 | CID000092066 | |
| Drug | crizotinib | 1.82e-04 | 53 | 121 | 4 | ctd:C551994 | |
| Drug | aqua regia | 2.09e-04 | 22 | 121 | 3 | CID000062687 | |
| Drug | Sp-8-Cl-cAMPS | 2.09e-04 | 22 | 121 | 3 | CID000133987 | |
| Drug | 2-(aminomethyl)pyrrolidine | 2.24e-04 | 161 | 121 | 6 | CID000072032 | |
| Drug | KN-62 | 2.33e-04 | 230 | 121 | 7 | CID000003838 | |
| Drug | vanadyl | 2.40e-04 | 307 | 121 | 8 | CID000061671 | |
| Drug | AC1MU1S9 | TRPC3 PTH1R GAB2 PIK3C2B PRKACA PRKACB PRKACG PKN2 PLD1 PLD2 ALOX5 | 2.41e-04 | 572 | 121 | 11 | CID000003733 |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 2.46e-04 | 308 | 121 | 8 | CID000001915 | |
| Drug | LY83583 | 2.47e-04 | 105 | 121 | 5 | CID000003976 | |
| Drug | 20-HETE | 2.58e-04 | 106 | 121 | 5 | CID005283157 | |
| Drug | tetraethylammonium | 2.73e-04 | 236 | 121 | 7 | CID000005413 | |
| Drug | AC1L19AY | 2.73e-04 | 24 | 121 | 3 | CID000000468 | |
| Drug | octadec-9-en-1-amine | 2.73e-04 | 24 | 121 | 3 | CID000008219 | |
| Drug | pulmatin | 2.77e-04 | 5 | 121 | 2 | CID000442731 | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 2.80e-04 | 314 | 121 | 8 | CID000003542 | |
| Drug | HA1004 | 2.93e-04 | 109 | 121 | 5 | CID000003546 | |
| Drug | dioxamate | 2.94e-04 | 60 | 121 | 4 | CID000045285 | |
| Drug | indolizidine | 3.09e-04 | 25 | 121 | 3 | CID000026136 | |
| Disease | hemoglobin A1 measurement | MGAM TRPS1 GAB2 MLXIPL FADS2 USP4 PKN2 ATP11A PLD1 ANO3 YTHDF2 | 6.26e-06 | 520 | 115 | 11 | EFO_0007629 |
| Disease | blood urea nitrogen measurement | 1.15e-05 | 452 | 115 | 10 | EFO_0004741 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.19e-05 | 195 | 115 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | developmental cardiac valvular defect (implicated_via_orthology) | 1.51e-05 | 2 | 115 | 2 | DOID:0080633 (implicated_via_orthology) | |
| Disease | cataract 48 (implicated_via_orthology) | 1.51e-05 | 2 | 115 | 2 | DOID:0070354 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 4.75e-05 | 51 | 115 | 4 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.10e-04 | 24 | 115 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.10e-04 | 24 | 115 | 3 | C3805278 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.23e-04 | 65 | 115 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | Cholangiocarcinoma | 1.40e-04 | 26 | 115 | 3 | C0206698 | |
| Disease | muscular disease (implicated_via_orthology) | 1.49e-04 | 5 | 115 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.56e-04 | 69 | 115 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | body surface area | 2.16e-04 | 643 | 115 | 10 | EFO_0022196 | |
| Disease | brain disease (implicated_via_orthology) | 2.24e-04 | 6 | 115 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | reticulocyte measurement | ATR INSR TRPS1 MYO1B GAB2 GSPT1 MLXIPL USP4 PKN2 ATP11A PLD1 ALOX5 DNMT3A | 2.39e-04 | 1053 | 115 | 13 | EFO_0010700 |
| Disease | fatty liver disease (implicated_via_orthology) | 2.39e-04 | 31 | 115 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | free cholesterol in large HDL measurement | 2.63e-04 | 79 | 115 | 4 | EFO_0022157 | |
| Disease | response to bronchodilator | 4.15e-04 | 8 | 115 | 2 | GO_0097366 | |
| Disease | valine measurement | 5.13e-04 | 40 | 115 | 3 | EFO_0009792 | |
| Disease | lymphocyte count | MANBA ACACA SANBR SFI1 PTH1R GAB2 MST1R BTN2A3P FADS2 ROBO2 USP4 PKN2 SKAP2 DNMT3A PSD4 | 5.71e-04 | 1464 | 115 | 15 | EFO_0004587 |
| Disease | serum alanine aminotransferase measurement | MANBA INSR TRPS1 SRMS MLXIP GAB2 MLXIPL FADS2 PKN2 CCDC102B ALOX5 | 5.98e-04 | 869 | 115 | 11 | EFO_0004735 |
| Disease | S-6-hydroxywarfarin measurement | 6.13e-04 | 368 | 115 | 7 | EFO_0803326 | |
| Disease | triglyceride measurement, alcohol drinking | 6.20e-04 | 99 | 115 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | vitamin B6 measurement | 6.64e-04 | 10 | 115 | 2 | EFO_0004621 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 6.68e-04 | 101 | 115 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | free cholesterol in medium VLDL measurement | 8.25e-04 | 47 | 115 | 3 | EFO_0022269 | |
| Disease | nervous system disease (implicated_via_orthology) | 9.69e-04 | 12 | 115 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 9.69e-04 | 12 | 115 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in large LDL percentage | 1.05e-03 | 51 | 115 | 3 | EFO_0022331 | |
| Disease | age at menopause | 1.21e-03 | 302 | 115 | 6 | EFO_0004704 | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.31e-03 | 55 | 115 | 3 | EFO_0022234 | |
| Disease | actinic keratosis | 1.33e-03 | 14 | 115 | 2 | EFO_0002496 | |
| Disease | cholesterol to total lipids in large LDL percentage | 1.38e-03 | 56 | 115 | 3 | EFO_0022235 | |
| Disease | low density lipoprotein particle size measurement | 1.52e-03 | 58 | 115 | 3 | EFO_0008593 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 1.53e-03 | 15 | 115 | 2 | OBA_2045165 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 1.60e-03 | 59 | 115 | 3 | EFO_0022248 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 1.68e-03 | 60 | 115 | 3 | EFO_0022282 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.74e-03 | 220 | 115 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | free cholesterol in very large HDL measurement | 1.84e-03 | 62 | 115 | 3 | EFO_0022273 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.88e-03 | 224 | 115 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | macrophage inflammatory protein 1b measurement | 2.01e-03 | 136 | 115 | 4 | EFO_0008219 | |
| Disease | total lipids in very large HDL measurement | 2.21e-03 | 66 | 115 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 2.21e-03 | 66 | 115 | 3 | EFO_0022298 | |
| Disease | phosphatidylcholine 36:4 measurement | 2.21e-03 | 18 | 115 | 2 | EFO_0010382 | |
| Disease | phospholipid measurement | 2.23e-03 | 140 | 115 | 4 | EFO_0004639 | |
| Disease | squamous cell carcinoma | 2.30e-03 | 67 | 115 | 3 | EFO_0000707 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 2.47e-03 | 19 | 115 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | cholesterol in very large HDL measurement | 2.51e-03 | 69 | 115 | 3 | EFO_0022229 | |
| Disease | Manic Disorder | 2.72e-03 | 71 | 115 | 3 | C0024713 | |
| Disease | platelet component distribution width | 2.83e-03 | 755 | 115 | 9 | EFO_0007984 | |
| Disease | phospholipids in large HDL measurement | 2.94e-03 | 73 | 115 | 3 | EFO_0022190 | |
| Disease | urate measurement, bone density | 2.98e-03 | 619 | 115 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | total lipids in large HDL | 3.06e-03 | 74 | 115 | 3 | EFO_0022189 | |
| Disease | Seckel syndrome | 3.31e-03 | 22 | 115 | 2 | C0265202 | |
| Disease | fat intake measurement | 3.31e-03 | 22 | 115 | 2 | EFO_0010809 | |
| Disease | phosphatidylcholine 34:3 measurement | 3.31e-03 | 22 | 115 | 2 | EFO_0010377 | |
| Disease | asparaginase hypersensitivity | 3.42e-03 | 77 | 115 | 3 | EFO_0004881 | |
| Disease | Manic | 3.55e-03 | 78 | 115 | 3 | C0338831 | |
| Disease | very low density lipoprotein cholesterol measurement | 3.57e-03 | 260 | 115 | 5 | EFO_0008317 | |
| Disease | Depression, Bipolar | 3.68e-03 | 79 | 115 | 3 | C0005587 | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 3.77e-03 | 162 | 115 | 4 | EFO_0004612, EFO_0007878 | |
| Disease | forced expiratory volume | MICAL1 LARS2 PIK3C2B ANKDD1A PITPNM3 CTNND2 SKAP2 ANKFN1 GAB1 | 3.79e-03 | 789 | 115 | 9 | EFO_0004314 |
| Disease | cholesterol in large HDL measurement | 3.81e-03 | 80 | 115 | 3 | EFO_0021900 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AWKFFRDKWKILNTR | 936 | Q9UKU6 | |
| KRKYWALTSLKWILS | 396 | Q96KV6 | |
| KWRTLTSKVRRWENY | 231 | B9A014 | |
| FYKLRWLEAILSWQK | 266 | Q6UX73 | |
| KEKYSNDWWIGRLVK | 96 | P54284 | |
| YYISKRKRDEWLARW | 196 | Q9Y6K1 | |
| KLIFFYEWSVKLNWT | 76 | O95433 | |
| LWTFLFRVRVWKPYA | 36 | O00270 | |
| LDWKTSRTFFYWRLR | 2206 | Q13085 | |
| KTWIFWKTWIFRKTY | 186 | P51861 | |
| WKTWIFRKTYIGWKT | 191 | P51861 | |
| GSWKWSVYIRAAVRK | 876 | Q9UQB3 | |
| WVWKIDVASFFGKRR | 1081 | Q6IQ32 | |
| IWATVFLEFWKRRRS | 481 | Q9BYT9 | |
| SYEWNEWELRRKAIK | 531 | Q8IYR0 | |
| WWMLRRSLKKYSFES | 341 | Q8IWT6 | |
| KKKENREDFWSYRWI | 391 | Q6NSI4 | |
| ILEWKTARTFLYWRL | 2316 | O00763 | |
| TRVLAWKIFSTKEWF | 31 | O95170 | |
| ALWAVLLLEYWKRKS | 431 | Q6IWH7 | |
| WKRKSATLAYRWDCS | 441 | Q6IWH7 | |
| WLVIDRKVYNITKWS | 36 | O95864 | |
| YELQASRWEWKRLKA | 111 | P51610 | |
| YQRTLLKKVWKVWRS | 276 | Q8NA72 | |
| KKYEEREQARWSLWE | 831 | A0AUZ9 | |
| KWFATTDWIAIYQRK | 296 | P17612 | |
| WVRTRIKAFLIWAYF | 121 | Q8WWC4 | |
| ARKVYWFEKFLWFIS | 521 | O60524 | |
| AKTWSRYAKELLAWT | 101 | Q9P107 | |
| IYRAKSILDSWVWGK | 91 | O95714 | |
| LKRYAWKRRWFVLRS | 21 | Q13480 | |
| RKLFIRLYPGSWWDK | 1021 | P54707 | |
| FFRNSTAKWWKREIE | 2281 | O43451 | |
| LKTFVFFIWRRYWRT | 1746 | A9Z1Z3 | |
| RWWKISLRSEYRSTK | 36 | Q8NEA4 | |
| WEDYVLRLWRKYSNK | 161 | Q9NX47 | |
| NYWSAKSLWTKLDKR | 56 | Q8TDZ2 | |
| RYILKTKFREMWKSW | 161 | Q9NX02 | |
| AVDWVSRKLYWLDAR | 3276 | P98164 | |
| RTSFDKILLRWEPYW | 506 | P06213 | |
| REAKEKNRETWYLSW | 111 | P15170 | |
| IKRKWRSWKVNRYFA | 411 | P41586 | |
| VIDYRRWIKEKWGSK | 521 | Q5XG87 | |
| ESLYWLTDADKKRLW | 826 | O00750 | |
| WKSRIEIVIREYHKW | 211 | Q9HAP2 | |
| RLAELYVERAKWLWS | 1951 | Q13535 | |
| PIFSLFRKWKAFSVW | 271 | Q9C0G6 | |
| KWFATTDWIAIYQRK | 296 | P22694 | |
| KWFATTSWIAIYEKK | 296 | P22612 | |
| RISKSKFSRYWRRWN | 496 | Q13936 | |
| RFGTKRWRKTWAVLY | 16 | Q99704 | |
| FTDWYKTPTKHRLRW | 251 | Q8NCQ5 | |
| TWKRRWFILTDNCLY | 276 | Q99418 | |
| WKTRWFTLHRNELKY | 181 | Q9UN19 | |
| TWKRRWFILTDNCLY | 281 | O43739 | |
| VWKRWKKRYFVLVQV | 501 | Q86UW7 | |
| FRKTSRKEDWYIWQV | 301 | Q8NFW1 | |
| DWEAYWRLLFKKISL | 96 | Q8WXX5 | |
| RWVSLDNWTYSKEFK | 71 | O00462 | |
| NWEASIWKFFFRKLT | 236 | A6NNS2 | |
| QWLKKCFWTYRTRVL | 201 | Q8IXQ9 | |
| FSREDLVWYKKVLWE | 2311 | Q9BYK8 | |
| LVWYKKVLWEARKFE | 2316 | Q9BYK8 | |
| KKWHWRARTSALYFS | 36 | Q4AE62 | |
| SKAPLAYVKRWLWTA | 171 | Q8WTZ4 | |
| WLDWAKEKYDERLIS | 261 | P46059 | |
| ERLESALSLWKWKYE | 286 | Q68D86 | |
| KFEAWSKRAWTDVFL | 1691 | Q6ZTR5 | |
| WRFYLSFRKLMRWIL | 791 | Q8IZU8 | |
| DGYIYTWTKSRFWRK | 221 | P15086 | |
| ESKRWSKIWLLFFVE | 111 | Q8N9I5 | |
| FRKWKWYQFTSLRDL | 711 | Q12756 | |
| FWIDTKNYVEVTRKW | 261 | Q13505 | |
| EDIVNSWFWSRKYTK | 701 | Q5JY77 | |
| SWFWSRKYTKPEAII | 706 | Q5JY77 | |
| KLRRYAWKKRWFILR | 21 | Q9UQC2 | |
| WKSWLIYVVVRRTKL | 191 | A8K8P3 | |
| KKYSRRSWDQQIKLW | 176 | Q14493 | |
| SDKLKDWLISRQRYW | 441 | Q15031 | |
| SWYYEKKSRSSWRLT | 1781 | P12259 | |
| YDWLLAKIWVRSSDF | 346 | P09917 | |
| ACYRWSKRWLIVKDS | 246 | Q13393 | |
| YIEKLWLSFWNSKAS | 391 | P48378 | |
| EWQKRWCALSKTVFY | 136 | O75563 | |
| KLNIWDWKTTKLYSR | 531 | O60508 | |
| LKALYWSIRSEKLEW | 726 | Q8NDX1 | |
| YWRDWRSLCAVKFLR | 436 | Q16513 | |
| RRRLAFLSFFWDKIW | 6 | Q9H3Y6 | |
| LFEELKSWRDVYWRL | 376 | Q6NSI8 | |
| IWRAWYIQYVKRRKS | 126 | Q9NP71 | |
| WRLASRYLQPREWKK | 416 | Q495B1 | |
| REWKKLAYSWEFTEA | 426 | Q495B1 | |
| KQLKAWEWRYRLYRR | 246 | Q8N957 | |
| YRWELKDSNKEFWLL | 71 | Q8TAZ6 | |
| EAKVIRWFDYLWTNK | 406 | Q16280 | |
| RWFDYLWTNKKTVDE | 411 | Q16280 | |
| KDLETRVIRWFDYLW | 431 | Q16281 | |
| RVIRWFDYLWANKKT | 436 | Q16281 | |
| KNALLRWRVFIYWTL | 956 | P98196 | |
| VKILERWWGTKRIDY | 826 | O00562 | |
| SEADWLRFWSKYKLS | 1106 | Q9UHF7 | |
| IWRFAWRKSIKKYHA | 211 | Q6ZRR5 | |
| LIDSRWFKQWKKYVG | 36 | Q13107 | |
| KDIVWFLKRWAKTYL | 636 | Q9C0E2 | |
| SATRRKWKHYWVSLK | 456 | Q13009 | |
| ARRKWKQYWVTLKGC | 531 | Q8IVF5 | |
| LSDWFDNKTDLYRWK | 2501 | O60673 | |
| KKSWSRWTLALDFKR | 471 | Q03431 | |
| KIAAWRWSRKIGKLY | 716 | Q96IC2 | |
| WDLTQSWRRKYTLFS | 311 | Q8TEQ6 | |
| FSIWLYWRRKKRKGL | 876 | Q9HCK4 | |
| KWTLSRFFSYLRSWD | 321 | Q9BWV7 | |
| RWSDIRKDSFWLYFS | 96 | O75310 | |
| RITAKWWGSKRIDYA | 541 | Q9BZ71 | |
| LRTTWDFWRKMYLRE | 176 | A6NK53 | |
| LSRARDWAWEKVKFY | 286 | Q9H598 | |
| RWEWLYSIYRKGTKA | 86 | Q5T742 | |
| YVSWVKRKQDEWIKF | 436 | P54578 | |
| WSSRLRISSYVNWIK | 1041 | Q5T4S7 | |
| ELRHLYLTEKYVWRW | 4091 | Q5T4S7 | |
| YRWSKRWLVVKDSFL | 231 | O14939 | |
| ALATALVFSYWWRRK | 971 | Q04912 | |
| WKGRFDVRWIFVKDV | 491 | Q9Y5A9 | |
| IRGWKSRWFFYDERK | 61 | Q9BYX2 | |
| VEWKFARSKLWLSYF | 671 | Q13507 | |
| EWKFARAKLWLSYFD | 686 | Q9HCX4 | |
| WRREATKYARWIAFT | 91 | Q8NHV5 | |
| VDIWTTVLDLKWRYK | 66 | P48048 | |
| WAYWLGSKARRELKR | 816 | O43795 | |
| WYRDDVLLKESKWTK | 316 | P54296 |